Publicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Lleida (107)

2024

  1. Association between adherence to the mediterranean diet, physical activity, and sleep apnea-hypopnea syndrome (SAHS) in a middle-aged population with cardiovascular risk: Insights from the ILERVAS cohort

    Sleep Medicine, Vol. 116, pp. 19-26

  2. COVID-19 and cardiovascular disease in patients with chronic kidney disease

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 2, pp. 177-189

  3. Gender-specific risk factors and outcomes of hyperkalemia in CKD patients: smoking as a driver of hyperkalemia in men

    Clinical Kidney Journal, Vol. 17, Núm. 1

  4. Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum

    Frontiers in Endocrinology, Vol. 15

  5. Role of Advanced Glycation End Products as New Biomarkers in Systemic Lupus Erythematosus

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

  6. Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease

    Clinical Kidney Journal, Vol. 17, Núm. 3

2023

  1. Antihypertensive Effects of an Optimized Aged Garlic Extract in Subjects with Grade I Hypertension and Antihypertensive Drug Therapy: A Randomized, Triple-Blind Controlled Trial

    Nutrients, Vol. 15, Núm. 17

  2. B- and T-lymphocyte attenuator could be a new player in accelerated atherosclerosis associated with chronic kidney disease

    Clinical science (London, England : 1979), Vol. 137, Núm. 17, pp. 1409-1429

  3. Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease

    Science translational medicine, Vol. 15, Núm. 712, pp. eabn5939

  4. Cumulative tobacco consumption has a dose-dependent effect on atheromatosis burden and improves severe atheromatosis prediction in asymptomatic middle-aged individuals: The ILERVAS study

    Atherosclerosis, Vol. 375, pp. 75-83

  5. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis

    JAMA, Vol. 330, Núm. 13, pp. 1266-1277

  6. Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP

    European Journal of Preventive Cardiology, Vol. 30, Núm. 1, pp. 8-16

  7. Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients

    Scientific Reports, Vol. 13, Núm. 1

  8. Is There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project

    Nutrients, Vol. 15, Núm. 1

  9. Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort

    Atherosclerosis, Vol. 380

  10. Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study

    European heart journal, Vol. 44, Núm. 13, pp. 1157-1166

  11. Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 1, pp. 10-25

  12. Polyvascular Subclinical Atherosclerosis: Correlation Between Ankle Brachial Index and Carotid Atherosclerosis in a Population-Based Sample

    Angiology, Vol. 74, Núm. 5, pp. 443-451

  13. SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2444-2455

  14. Vitamin D Receptor From VSMCs Regulates Vascular Calcification During CKD: A Potential Role for miR-145a

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 43, Núm. 8, pp. 1533-1548